Talk:Efficacy of naloxone in reducing postictal central respiratory dysfunction in patients with epilepsy: study protocol for a double-blind, randomized, placebo-controlled trial

From SUDEP Wiki
Revision as of 03:55, 5 January 2018 by JYK (talk | contribs) (Created page with " Although the exact pathophysiologic mechanisms that lead to SUDEP remain unknown, most experts seem to agree on the predominant role of central respiratory dysfunction that o...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Although the exact pathophysiologic mechanisms that lead to SUDEP remain unknown, most experts seem to agree on the predominant role of central respiratory dysfunction that occurs within 1-3 minutes after a convulsive seizure as a major risk to progressing into SUDEP. This study is amongst the first to target this time window with a pharmacological intervention based on the hypothesis that SUDEP results partly from postictal apnea promoted by a GTCS-induced massive release of endogenous opioid.

See also: Richerson GB, Boison D, Faingold CL, Ryvlin P. From unwitnessed fatality to witnessed rescue: pharmacologic intervention in sudden unexpected death in epilepsy. Epilepsia. 2016;57(Suppl 1):35–45.

Retrieved from "https://sudepwiki.pathology.jhmi.edu/index.php?title=Talk:Efficacy_of_naloxone_in_reducing_postictal_central_respiratory_dysfunction_in_patients_with_epilepsy:_study_protocol_for_a_double-blind,_randomized,_placebo-controlled_trial&oldid=862"